Description

Advanced Microbiome Mapping Test

The landscape of microbiology and gut health testing has been revolutionised by the advancements in PCR technology and extensive research efforts worldwide. This deeper understanding has illuminated the remarkable interplay between the microorganisms inhabiting our GI tract and their profound impact on our overall health, encompassing both the benefits they bring and the risks they pose in terms of disease susceptibility.

The Advanced Microbiome Mapping has been meticulously designed to comprehensively assess a patient’s microbiome through a single stool sample. This panel assesses a diverse array of microbial targets (both commensal and opportunistic), fungi, yeast, parasites, as well as immune and digestive markers.

The inclusion of additional sensitivity testing through culture is what sets The Advanced Microbiome Mapping Test apart from other PCR panels. By subjecting the isolated microbial strains to sensitivity testing, healthcare professionals gain invaluable insights into how these microorganisms respond to various treatment options and helps pinpoint the most effective therapeutic strategies. This targeted approach not only minimises the overuse of broad-spectrum antibiotics, which can lead to antibiotic resistance, but also optimises treatment outcomes by tailoring interventions to the individual.